Figure 1: Summary of the deal
|
Type of issue |
Shares (mn) |
Value (S$mn) |
Per Share |
Rights Entitlement |
|
Existing |
1,185 |
6,519 |
5.50 |
|
|
New issues |
1,778 |
5,333 |
3.00 |
3 for 2 |
|
TERP |
2,963 |
11,852 |
4.00 |
|
|
Right MCB |
723 |
3,500 |
4.84 |
295:100 |
|
3,686 |
15,352 |
4.16 |
||
|
Additional MCB |
n.a. |
6,200 |
n.a. |
Source: Company PSR; TERP = theoretical ex-rights price, MCB = mandatory convertible bonds
Part 1: Rights issue of ordinary shares will raise S$5.3bn
Up to 1.777bn Rights Shares will be issued at an issue price of S$3.00 for each Rights Share on the basis of three (3) Rights Shares for every two (2) existing ordinary shares of SIA.
The Rights Shares represents a discount of approximately 45.5% to the SIA’s last traded price of S$5.50 on 3 April 2020 and a discount of approximately 25% to the theoretical ex-rights price (TERP) of S$4.00 per Share.
Below is an example of a shareholder with 1,000 existing SIA shares:
Figure 2: Every 1000 shares held, the shareholder will need to fork out ….
|
Current: 1,000 shares @ S$5.50 |
S$5,500 |
|
|
|
|
To subscribe for the rights: |
|
|
Rights Shares: 1,500 shares @ S$3.00 |
S$4,500 |
|
Rights MCB: 295:100 |
S$2,950 |
|
Total additional cash investment needed to prevent dilution |
S$7,450 |
Source: Company, PSR
Rights Shares rights can be sold in the open market if investors do not wish to exercise them.
Part 2: Rights issue of mandatory convertible bonds will raise S$3.5bn
295 Rights MCBs will be issued for every 100 existing ordinary shares to raise up to S$3.5bn. In other words, an existing shareholder with 1,000 SIA shares can purchase S$2,950 worth of MCBs.
The MCB is a zero-coupon bond converted into SIA shares at maturity or redemption by SIA. There will be no coupon interest paid. At the maturity date of 10 years, SIA will mandatorily convert all MCBs into shares. The number of Shares to be delivered to bondholders in respect of its holding of Rights MCBs will be determined by dividing the Accreted Principal Amount of the Rights MCBs held by such Bondholder as at the Maturity Date by the Conversion Price of S$4.84, which is at a premium of 21% to the TERP of S$4.00 per Share.
Bondholders will receive 373 shares for every S$1,000 invested in Rights MCBs today. At the maturity date, the Accreted Principal Amount will be S$1,806.11 for each S$1,000 invested in the Rights MCB. This means, if an investor invests S$1,000 in MCBs today, the MCB value will be S$1,806.11 at maturity date and the investor will receive S$1,806.11 / S$4.84 = 373 new SIA shares.
MCBs can be redeemed early at SIA’s discretion. The Rights MCBs may be redeemable at the option of SIA in whole or in part on every six-month anniversary of the issue date. In the event of early redemption, bondholders will receive in cash the relevant Accreted Principal Amount as at such semi-annual Date. The Redemption Price set out below has been calculated on the basis that the annual yield to call for the first 4 years from the date of issue of the Rights MCBs is 4% per annum, and the subsequent 3 years is 5% per annum and the subsequent 3 years is 6% per annum, compounded on a semi-annual basis.
Figure 3: Redemption schedule of the MCBs
Source: SIA circular dated 26 March 2020, PSR
For example, if a bondholder invested S$1,000 in Rights MCB and SIA redeems the whole amount early on the 4th Semi-Annual Date, the redemption price will be S$1,082.43 (108.243% x S$1,000) which bondholders will receive in cash, representing an annual compounded return of 4%.
Investors risk loss if SIA share price falls below the conversion price of S$4.84. If SIA share price falls below S$4.84 when the MCBs are redeemed, a loss will be incurred from paying a higher price to receive the new SIA shares at the redemption or maturity date.
The Rights MCBs are intended to be tradable on the active market. Investors may liquidate their Rights MCBs if they do not which to exercise them. They will also be able to liquidate MCBs that they have subscribed for by selling on the active market.
Part 3: SIA may issue S$6.2bn additional MCBs in the next 15 months
There may be a further issuance of up to approximately S$6.2bn aggregate principal amount of additional mandatory convertible bonds (the Additional MCBs) within 15 months commencing from the date of the approval by Shareholders for the issue of the Rights MCBs at the EGM.
Proceeds to help with cash flow
The proceeds from the Rights Issue and any future issue of the Additional MCBs, which will be treated as equity in the balance sheet of the Company, will strengthen the Company’s balance sheet and liquidity position and enable the Company to meet its ongoing financial commitments, weathering the severe disruption to global air travel caused by the COVID-19 pandemic.
Figure 4: Redemption
Source: SIA circular dated 26 March 2020, PSR
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
